Lumayag, Melchecedic L.
HRN: 05-63-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/16/2025
06/22/2025
IV
1.5g
Q6h
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes